Mirvie Announces Results from Largest Molecular Study in Pregnancy and Clinical Validation of Simple Blood Test to Predict Risk for Preeclampsia Months Before Symptoms

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Research from Mirvie has uncovered the biology of preeclampsia, providing unprecedented clarity on pregnancies with the highest risk of the condition.